disease in about 15% of patients. [ 19 , 21 ] LMWH is the preferred initial anticoagulant followed by vitamin K antagonists (target INR between 2 and 3). [ 9 ] Ascites is managed with diuretics and low saltdiet. Underlying prothrombotic conditions should be extensively looked for and be treated promptly.
Primarily data shows that new oral anticoagulants (NOACs) are effective and safe in patients with splanchnic venous thrombosis and cirrhosis; however, there are no data to support their usage in patients with BCS as yet. [ 22 ]